Zobrazeno 1 - 10
of 219
pro vyhledávání: '"Philip M Arlen"'
Autor:
Peter R Rhode, Hing C Wong, Jack O Egan, Jeffrey S Miller, Manish Patel, Martin Felices, Philip M Arlen, Melissa A Geller, Pallavi Chaturvedi, Shannon Lunn, Bethany Hanke, Rose Wangen, Niraj Shrestha, Danieska Sandino, Karen L Kage, Delsy G Gaetano, Giles M Leclerc, Zhu Xiaoyun, Kelsey Mullen, Deepa Kolaseri Krishnadas
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/d8b2105461264571a36a107623d60fc8
Autor:
Harpreet Singh, Seth Steinberg, Lisa Cordes, Helen Owens, Amy Hankin, Anna Couvillon, Marc R Theoret, Munjid Al-Harthy, Inger I Rosner, Philip M Arlen, Moniquea Williams, Sarah E Lochrin, Cindy H Chau, William Douglas Figg, William Dahut
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background The standard treatment for non-metastatic castration sensitive prostate cancer (nmCSPC) is androgen deprivation therapy (ADT) or surveillance. This study evaluated the potential synergy of immunotherapy and enzalutamide (without ADT) in nm
Externí odkaz:
https://doaj.org/article/ef49fdba74d849a0ab9d4e9c35ca2842
Autor:
Kwong yok Tsang, Massimo Fantini, Sharon A. Mavroukakis, Anjum Zaki, Christina M. Annunziata, Philip M. Arlen
Publikováno v:
Cancers, Vol 14, Iss 13, p 3037 (2022)
NEO-201 is an IgG1 humanized monoclonal antibody (mAb) that binds to tumor-associated variants of carcinoembryonic antigen-related cell adhesion molecule (CEACAM)-5 and CEACAM-6. NEO-201 reacts to colon, ovarian, pancreatic, non-small cell lung, head
Externí odkaz:
https://doaj.org/article/afc17848ec1f405296af904532136bee
Autor:
Kristen P. Zeligs, Maria Pia Morelli, Justin M. David, Monica Neuman, Lidia Hernandez, Stephen Hewitt, Michelle Ozaki, Akosua Osei-Tutu, David Anderson, Thorkell Andresson, Sudipto Das, Justin Lack, Abdalla Abdelmaksoud, Massimo Fantini, Philip M. Arlen, Kwong Y. Tsang, Christina M. Annunziata
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Purpose: Despite high initial response rates with cytoreductive surgery, conventional chemotherapy and the incorporation of biologic agents, ovarian cancer patients often relapse and die from their disease. New approaches are needed to improve patien
Externí odkaz:
https://doaj.org/article/e7c630372871404ba4799461b16ca534
Autor:
Ravi A Madan, Marijo Bilusic, Mark N Stein, Renee N Donahue, Philip M Arlen, Fatima Karzai, Elizabeth Plimack, Yu-Ning Wong, Daniel M Geynisman, Matthew Zibelman, Tina Mayer, Julius Strauss, Gang Chen, Myrna Rauckhorst, Sheri McMahon, Anna Couvillon, Seth Steinberg, William D Figg, William L Dahut, Jeffrey Schlom, James L Gulley
Publikováno v:
Oncologist
Background Before 2018, there was no standard of care for non-metastatic (M0) castration resistant prostate cancer nmCRPC. Androgen receptor antagonists (ARAs) were commonly used sequentially nmCRPC. Methods This was a multicenter, randomized clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f42ae97eefbd0c6b18ed912192756d91
https://europepmc.org/articles/PMC10322134/
https://europepmc.org/articles/PMC10322134/
Autor:
Christopher B. Cole, Maria Pia Morelli, Massimo Fantini, Markku Miettinen, Patricia Fetsch, Cody Peer, William D. Figg, Tyler Yin, Nicole Houston, Ann McCoy, Stanley Lipkowitz, Alexandra Zimmer, Jung-min Lee, Miroslava Pavelova, Erin N. Villanueva, Kathryn Trewhitt, B. Brooke Solarz, Maria Fergusson, Sharon A. Mavroukakis, Anjum Zaki, Kwong Y. Tsang, Philip M. Arlen, Christina M. Annunziata
Publikováno v:
Journal of Experimental & Clinical Cancer Research. 42
Autor:
James L. Gulley, Jeffrey Schlom, Ravi A. Madan, Philip M. Arlen, William Dahut, Timothy C. Rodell, Italia Grenga, Renee N. Donahue, Jennifer L. Marté, Myrna Rauckhorst, B. Harpreet Singh, Christopher R. Heery
The nuclear transcription factor brachyury has previously been shown to be a strong mediator of the epithelial-to-mesenchymal transition (EMT) in human carcinoma cells and a strong negative prognostic factor in several tumor types. Brachyury is overe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0becb600fac999b1ab9b666f3a79d0d9
https://doi.org/10.1158/2326-6066.c.6548917.v1
https://doi.org/10.1158/2326-6066.c.6548917.v1
Autor:
James L. Gulley, Jeffrey Schlom, Ravi A. Madan, Philip M. Arlen, William Dahut, Timothy C. Rodell, Italia Grenga, Renee N. Donahue, Jennifer L. Marté, Myrna Rauckhorst, B. Harpreet Singh, Christopher R. Heery
Yeast-brachyury progression-free survival; chordoma patients only.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bddfe2217ca958767a441d5ee485df8
https://doi.org/10.1158/2326-6066.22538860.v1
https://doi.org/10.1158/2326-6066.22538860.v1
Autor:
Jeffrey Schlom, William L. Dahut, Herbert Kotz, Seth M. Steinberg, James W. Hodge, Jack P. Higgins, Mary P. Pazdur, Jacquin L. Jones, Vittore Cereda, Cinzia Remondo, Diane J. Poole, Claudia Palena, Junko Yokokawa, Kwong-Yok Tsang, Philip M. Arlen, James L. Gulley
Supplementary Data from Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52c8af7ecc80a59b46abf061226ce87d
https://doi.org/10.1158/1078-0432.22439665
https://doi.org/10.1158/1078-0432.22439665
Autor:
James L. Gulley, Jeffrey Schlom, William L. Dahut, Elizabeth C. Jones, Myrna Rauckhorst, Mary Pazdur, Seth M. Steinberg, Philip M. Arlen, Christopher R. Heery, Theresa Ferrara, Jacquin Jones, Caroline Jochems, Diane J. Poole, Ngar-Yee Huen, Ravi A. Madan, Kwong-Yok Tsang, Mahsa Mohebtash
Purpose: PANVAC is a recombinant poxviral vaccine that contains transgenes for MUC-1, CEA, and 3 T-cell costimulatory molecules. This study was conducted to obtain preliminary evidence of clinical response in metastatic breast and ovarian cancer pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fce3deba8bdd7c7796eecf66b09dab2
https://doi.org/10.1158/1078-0432.c.6519708.v1
https://doi.org/10.1158/1078-0432.c.6519708.v1